MedTrace Logo

Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis

NCT04626258 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 252

Last updated 2020-11-12

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of Flucanzol versus L-mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. The investigator will look at vaginal swabs after 1, 6 and 12 months. The investigator included 252 patients.

Conditions

  • Candidiasis, Vulvovaginal
  • Recurrent Candidiasis of Vagina

Interventions

DRUG

Fluconazole

Fluconazol once a month 150 mg capsule

OTHER

L-Mesitran

The first month apply every day one sachet, the next five months apply every week one sachet.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2024-03-01
Completion
2025-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04626258 on ClinicalTrials.gov